Invention Grant
- Patent Title: Radioactive labeling method for neuropeptide Y derivative compound and medicine for multi-type breast cancer therapy thereof
-
Application No.: US16215647Application Date: 2018-12-11
-
Publication No.: US11077217B2Publication Date: 2021-08-03
- Inventor: Ming-Hsin Li , Su-Jung Chen , Ming-Wei Chen , Yuan-Ruei Huang , Shih-Ying Lee , Chun-Fang Feng , Sheng-Nan Lo , Chih-Hsien Chang
- Applicant: Ming-Hsin Li , Su-Jung Chen , Ming-Wei Chen , Yuan-Ruei Huang , Shih-Ying Lee , Chun-Fang Feng , Sheng-Nan Lo , Chih-Hsien Chang
- Applicant Address: TW Taoyuan; TW Taoyuan; TW Taoyuan; TW Taoyuan; TW Taoyuan; TW Taoyuan; TW Taoyuan; TW Taoyuan
- Assignee: Ming-Hsin Li,Su-Jung Chen,Ming-Wei Chen,Yuan-Ruei Huang,Shih-Ying Lee,Chun-Fang Feng,Sheng-Nan Lo,Chih-Hsien Chang
- Current Assignee: Ming-Hsin Li,Su-Jung Chen,Ming-Wei Chen,Yuan-Ruei Huang,Shih-Ying Lee,Chun-Fang Feng,Sheng-Nan Lo,Chih-Hsien Chang
- Current Assignee Address: TW Taoyuan; TW Taoyuan; TW Taoyuan; TW Taoyuan; TW Taoyuan; TW Taoyuan; TW Taoyuan; TW Taoyuan
- Main IPC: A61K51/08
- IPC: A61K51/08 ; A61K51/04 ; A61K51/06
Abstract:
The present invention provides a radioactive labeling method for neuropeptide Y (NPY) compound and a mammalian diagnostic radioactive targeting medicine with NPY peptide being modified at position 27th to 36th, and after binding with the chelating agent and labeling the radiation nucleus 66Ga67Ga68Ga177Lu or 111In to provide a radioactive targeting medicine for multi-type breast cancer diagnosis and treatment.
Public/Granted literature
Information query
